Health Information Resource Database

[Inclusion of an information resource in this database does not imply endorsement
by the U.S. Department of Health and Human Services.]

Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Contact Information

Drug Information Branch
10001 New Hampshire Avenue
Hillandale Building, 4th Floor

Silver Spring, MD 20993

800-FDA-1088 (Voice - Toll-free)
888-463-6332 (Voice - Toll-free)
301-796-3400 (Voice)

Internet Resources

www.fda.gov/Drugs/default.htm

druginfo@fda.hhs.gov

Abstract

The Center for Drug Evaluation and Research (CDER) performs an essential public health task by making sure that safe and effective drugs are available to improve the health of people in the United States. As part of the U.S. Food and Drug Administration (FDA), CDER regulates over-the-counter and prescription drugs, including biological therapeutics and generic drugs. This work covers medicines and other drugs, including fluoride toothpaste, antiperspirants, dandruff shampoos and sunscreens.

Publications

CESS publications include labeling for FDA approved prescription drugs, CESS Fact Sheets, CESS information packets, FDA Consumer magazine reprints, drug information brochures, FDA Backgrounders, FDA Talk Papers, and FDA Medical Bulletin. CESS regulatory publications include guidelines, information packets, and Federal Register notices relative to the drug approval process. Information and guidance to order other regulatory manuals, directories, or drug evaluation reports are also available.

Keywords

You may search for other related entries in the database under the following topics.

Notes

Audit

Date Entered: 3/1/1998
Date Edited: 8/31/2012
Date Revised: 2/1/2001
Health Referral Number: HR0028
Accession Number: DP91A1094

NHIC Home Page